Topical vitamin B12 - A new therapeutic approach in atopic dermatitis - Evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 977-983

  Stucker M ^a   Pieck, C ^a   Stoerb, C ^a   Niedner, R ^b   Hartung, J ^c   Altmeyer, P ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b Ernst von Bergmann Clinic   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Atopic dermatitis; Inducible nitric oxide synthase; Nitric oxide; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; PLACEBO; DERMATOLOGICAL AGENT; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; BRONCHITIS; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FORMICATION; HUMAN; HYPERTHERMIA; MALE; METHODOLOGY; MULTICENTER STUDY; PATIENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; SCORING SYSTEM; SKIN DISEASE; SKIN IRRITATION; DRUG ANTAGONISM; HOSPITALIZATION; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; PATIENT SATISFACTION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN B 12;

EID: 3042701666     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05866.x     Document Type: Article

References (23)

1. 12 on in vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol 1992; 37: 173-82.
2. 12 on the in vitro immune functions of human T lymphocytes. J Clin Immunol 1982; 2: 101-9.
3. 12. Int J Tissue React 1982; 4: 95-101.
4. Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991; 24: 1097-101.
5. Sirsjö A, Karlsson M, Gidlöf A et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996; 134: 643-8.
6. Rowe A, Farrel AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997; 136: 18-23.
7. Ormerod AD, Weller R, Copeland P et al. Detection of nitric oxide and nitric oxide synthase in psoriasis. Arch Dermatol Res 1998; 290: 3-8.
8. Clark JE, Green CJ, Motterlini R. Involvement of the heme oxygenase-carbon monoxide pathway in keratinocyte proliferation. Biochem Biophys Res Commun 1997; 241: 215-20.
9. Berth-Jones J, Graham-Brown RA, Marks R et al. Long-term efficacy and safety of cyclosporine in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
10. Taniuchi S, Kojima T, Hara MK. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 2001; 56: 693-5.
11. Morita H, Semma M, Hori M, Kitano Y. Clinical application of NO synthase inhibitor for atopic dermatitis. Int J Dermatol 1995; 34: 294-5.
12. Linnell JC, Bhatt R. Inherited errors of cobalamin metabolism and their management. Baillière's Clin Haematol 1995; 8: 567-601.
13. 12 in the rat and guinea pig. J Nutr 1967; 92: 261-6.
14. 12 of value in psoriasis? Br Med J 1962; ii: 1729-30.
15. MacLennan A, Hellier FF. The treatment time in psoriasis. Br J Dermatol 1961; 73: 439-44.
16. 12 level in psoriatic skin and serum. Br J Dermatol 1969; 81: 911-18.
17. Berth-Jones J. Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl. 48): 25-30.
18. Hanifin JM. Standardized grading of subjects for clinical research studies in atopic dermatitis: workshop report. Acta Derm Venereol Suppl 1989; 144: 28-30.
19. British Industrial Biological Research Association (BIBRA) Working Group. Toxicity profile of avocado oil. Carshalton: TNO BIBRA International Ltd, 1990: 1-3.
20. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
21. Hartung J, Elpelt B, Klösener KH. Statistik: Lehr- und Handbuch der Angewandten Statistik, 12th edn. Munich: R.Oldenbourg-Verlag. 1999.
22. Jansen T, Romiti R, Kreuter A, Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol 2001; 15: 484-5.
23. 12 cream containing avocado oil in the therapy of plaque psoriasis. Dermatology 2001; 203: 141-7.